MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.34 1.83

Rezumat

Modificarea prețului

24h

Curent

Minim

3.27

Maxim

3.34

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+127.27% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-127M

169M

Deschiderea anterioară

1.51

Închiderea anterioară

3.34

Sentimentul știrilor

By Acuity

50%

50%

185 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 apr. 2026, 17:04 UTC

Principalele dinamici ale pieței

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 apr. 2026, 00:00 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Big Yachts, Big Bucks -- Barrons.com

10 apr. 2026, 21:55 UTC

Achiziții, Fuziuni, Preluări

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 apr. 2026, 21:01 UTC

Câștiguri

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 apr. 2026, 20:50 UTC

Market Talk
Evenimente importante

Basic Materials Roundup: Market Talk

10 apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 apr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 apr. 2026, 20:10 UTC

Achiziții, Fuziuni, Preluări

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 apr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 apr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 apr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 apr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 apr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 apr. 2026, 18:25 UTC

Market Talk
Evenimente importante

Precious Metals Finish With Weekly Gains -- Market Talk

10 apr. 2026, 18:05 UTC

Market Talk

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 apr. 2026, 17:31 UTC

Market Talk
Evenimente importante

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 apr. 2026, 17:26 UTC

Câștiguri

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 apr. 2026, 17:10 UTC

Market Talk

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 apr. 2026, 17:00 UTC

Evenimente importante

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 apr. 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

10 apr. 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 apr. 2026, 16:12 UTC

Câștiguri

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 apr. 2026, 16:11 UTC

Câștiguri

Partners Group: Traditional Programs Contributed $3.3B

10 apr. 2026, 16:10 UTC

Câștiguri

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 apr. 2026, 16:10 UTC

Câștiguri

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 apr. 2026, 16:10 UTC

Câștiguri

Partners Group 1Q New Client Demand $8.3B

10 apr. 2026, 16:09 UTC

Câștiguri

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 apr. 2026, 15:54 UTC

Achiziții, Fuziuni, Preluări

Plenitude Completes Acquisition of Acea Energia

10 apr. 2026, 15:38 UTC

Market Talk

Global Energy Roundup: Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

127.27% sus

Prognoză pe 12 luni

Medie 7.5 USD  127.27%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

185 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat